Immune Response, Organic Chemistry, Pharmaceuticals and Protein Expression

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

NOVEMBER 8, 2023

Presentations that follow include: Andres Perez Bay, PhD, Senior Staff Scientist, Oncology & Angiogenesis, Regeneron Pharmaceuticals, on: ‘A bispecific METxMET antibody-drug conjugate with cleavable linker is processed in recycling and late endosomes’. The presentations which follow include: Peter Tessier, PhD, Albert M.

Engineering

Engineering Protein Expression Therapies Science

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

NOVEMBER 13, 2023

Enkelejda Miho, PhD, Professor, University of Applied Sciences and Arts Northwestern Switzerland, and Managing Director, aiNET, on: ‘The singular immune response to dengue and machine learning identification of antibodies in high-throughput sequences’.

Engineering

Engineering Science Bioinformatics Vaccine

Drug Discovery Digest

What to expect from PEGS Europe 2023: Day 1

What to expect from PEGS Europe 2023: Day 3

Stay Connected